Teflaro is a type of antibiotic that is currently available only in brand-name form. Because this drug is protected by patents, companies are not allowed to make a generic Teflaro product. However, this may change after December 2018, when the first patent expires. Although ceftaroline fosamil is considered the "generic name" for Teflaro, it is not a generic version of it.
Is a Generic Version of Teflaro Available?
Teflaro® (ceftaroline fosamil) is a cephalosporin antibiotic that is given intravenously (by IV) to treat skin/skin structure infections or pneumonia. It is a "fifth-generation" cephalosporin.
This prescription medication is made by Facta Farmaceutici S.p.A. for Forest Pharmaceuticals, Inc. It was approved in 2010 and is not yet available in generic form.
When Will a Generic Version Be Available?
The first patent for Teflaro is set to expire in December 2018. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Teflaro uses. Once the patent expires, there may be several companies that manufacture a generic Teflaro drug.
Is Ceftaroline Fosamil a Generic Teflaro?
No -- ceftaroline fosamil is the active ingredient in Teflaro, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Teflaro [package insert]. St. Louis, MO: Forest Pharmaceuticals, Inc.;2010 October.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 20, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click